• Hydrochloroquine, well known in rheumatology, dermatology and tropical medicine is now considered in the treatment and prophylaxy for the SARS-CoVid19. • Mental and neurological manifestations should be assessed following the use of hydrochloroquine particularly following prophylactic use. • For acute malaria studies, hydroxychloroquine was associated with high prevalence of mental neurological manifestations amongst anti-malaria drugs. • Recommendations of using hydrochloroquine in COVID are variable and sometimes contradictory depending on agencies and countries.